| abstract |
(57) [Summary] (Modified) [Objective] To provide a novel sulfonamide dioxepane compound. [Structure] A sulfonamide dioxepane compound represented by the general formula (I), a pharmaceutically acceptable salt thereof, a method for producing the same, an intermediate for the production, and a therapeutic agent for diabetes containing the same. [In the formula, R 1 represents a C 1-4 alkyl group or a phenyl group, or, together with R 2 , represents a C 4-6 alkylidene group; R 3 represents a C 1-4 alkyl group, C 1-4 Represents a mono (or per) fluoroalkyl group, or a C 1-4 alkyl group, a phenyl group which may be mono-substituted with CF 3 , OH, F, Cl, Br, NH 2 and the like; Y represents a hydrogen atom, C 1-4 alkyl group, a benzyl group, -SO 2 R 3 groups, -COR 4 (wherein R 4 represents a C 1-4 alkyl group or a benzyl group)] |